The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments

Background No treatments are currently available that slow, stop, or reverse disease progression in established multiple sclerosis (MS). The Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS) trial tests the safety and feasibility of treatment with a candidate cell-based therapy, and will inform...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current controlled trials in cardiovascular medicine Jg. 12; H. 1; S. 62
Hauptverfasser:	Connick, Peter, Kolappan, Madhan, Patani, Rickie, Scott, Michael A, Crawley, Charles, He, Xiao-Ling, Richardson, Karen, Barber, Kelly, Webber, Daniel J, Wheeler-Kingshott, Claudia AM, Tozer, Daniel J, Samson, Rebecca S, Thomas, David L, Du, Ming-Qing, Luan, Shi L, Michell, Andrew W, Altmann, Daniel R, Thompson, Alan J, Miller, David H, Compston, Alastair, Chandran, Siddharthan
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 02.03.2011 BioMed Central Ltd Springer Nature B.V BMC
Schlagworte:	Adult Biomedicine Bone marrow Care and treatment Cell Proliferation Cells, Cultured Disability Evaluation England Factories Feasibility Studies Female Health Sciences Hepatitis Humans Magnetic Resonance Imaging Male Manufacturing Medicine Medicine & Public Health Mesenchymal Stem Cell Transplantation - adverse effects Mesenchymal Stem Cells - physiology Methodology Middle Aged Multiple sclerosis Multiple Sclerosis, Chronic Progressive - diagnosis Multiple Sclerosis, Chronic Progressive - surgery Optic nerve Patient outcomes Research Design Risk Assessment Statistics for Life Sciences Stem cells Time Factors Transplantation Transplantation, Autologous Treatment Outcome United Kingdom United Kingdom > UK Optical Coherence Tomography Retinal Nerve Fibre Layer Retinal Nerve Fibre Layer Thickness Magnetisation Transfer Ratio Diffusion Tensor Imaging
ISSN:	1745-6215, 1745-6215
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!